Back to search
Retinoblastoma
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Retinoblastoma trials may be worth asking aboutClinical trial pipeline · Data from ClinicalTrials.gov
See which Retinoblastoma trials may be worth asking aboutNorth America
Europe
Asia-Pacific
Rest of World
Trials may have sites in multiple countries. Filtering shows any trial with at least one site in the selected country.
Background: \- Laboratory investigators who are studying common childhood cancers are interested in developing a tissue repository to collect and store blood,…
To learn if the study drug REC-617 can help to control LMS. The safety of REC-617 will also be studied.
This is a single-arm, phase II study that will enroll a total of 45 subjects. All subjects will have a confirmed diagnosis of metastatic or unresectable soft ti…
NOTE: This is a research study and is not meant to be a substitute for clinical genetic testing. Families may never receive results from the study or may receiv…
This phase I/II trial tests the side effects and best dose of abemaciclib when added to gemcitabine and compares the effectiveness of that treatment to the usua…
The purpose of this study is to see if there is a difference between the development of the brain (neurodevelopment) in children who have been treated for retin…
The purpose of this study is to test the safety of combining Osimertinib with either Cisplatin or Carboplatin (at different dose levels) and Etoposide, to find…
Early Check provides voluntary screening of newborns for a selected panel of conditions. The study has three main objectives: 1) develop and implement an approa…